Previous 10 | Next 10 |
GT Biopharma Announces TriKE™ For The Treatment Of Breast And GI Cancers PR Newswire BEVERLY HILLS, Calif. , Dec. 28, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Co...
GT BIOPHARMA ANNOUNCES FDA DATA - GTB-3550 TriKE™ REDUCES CANCER CELLS BY 61.7% FOR A HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) PATIENT PR Newswire BEVERLY HILLS, Calif , Dec. 21, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno...
GT Biopharma ([[GTBP]] +1.8%) issued $1M of restricted common stock to Cytovance; number of shares was based on the closing price of $0.31 as on December 15, 2020."We are pleased to have the opportunity to work with Cytovance and their experienced team for the GMP manufacture of our TriK...
GT Biopharma And Cytovance Biologics Announce Milestone Achievement BEVERLY HILLS, Calif. , Dec. 17, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) a company focused on developing innovative therapeutic treatments based on its proprietary NK cell en...
GT Biopharma (GTBP) submitted an application to up-list its common stock to the NASDAQ Capital Market."..With the success of the data most recently presented at the ASH conference we have received tremendous institutional interest and believe that this transition will increase corporate visib...
GT Biopharma Submits Application for Uplisting to the NASDAQ Capital Market BEVERLY HILLS, Calif. , Dec. 14, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK c...
Why Should You Pay Attention to These Penny Stocks Right Now? When it comes to penny stocks , finding the biggest gainers of the day can be a good step in the right direction. This allows investors to see what type of momentum a penny stock has. In addition, it can help to identify ...
BEVERLY HILLS, CA / ACCESSWIRE / November 19, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology is pleased to announce Dr. Greg Berk, M.D. has joined the Com...
4 Biotech Penny Stocks To Watch Right Now Penny stocks remain red hot this week as markets turn up the heat on bullish momentum. Aside from speculation on what government measures will be taken in 2021, traders are also digesting several big vaccine updates. Last week we got new...
GT Biopharma (GTBP) appointed Michael Handelman, CPA as CFO.Most recently, Mr. Handelman served as CFO of Iovance Biotherapeutics. For further details see: GT Biopharma names new CFO
News, Short Squeeze, Breakout and More Instantly...
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025 GTB-5550 Phase 1 dose escalation basket trial initiation expected in 20...
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of 740,000 shares of the Company’s common stock at a purcha...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...